BTC Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $389K | Buy |
3,423
+327
| +11% | +$37.2K | 0.03% | 175 |
|
|
2025
Q1 | $326K | Sell |
3,096
-208
| -6% | -$21.9K | 0.03% | 186 |
|
|
2024
Q4 | $354K | Sell |
3,304
-131
| -4% | -$14K | 0.03% | 182 |
|
|
2024
Q3 | $344K | Sell |
3,435
-834
| -20% | -$83.5K | 0.03% | 193 |
|
|
2024
Q2 | $360K | Sell |
4,269
-336
| -7% | -$28.3K | 0.03% | 182 |
|
|
2024
Q1 | $337K | Buy |
+4,605
| New | +$337K | 0.03% | 194 |
|
|
2023
Q3 | $263K | Buy |
4,386
+658
| +18% | +$39.4K | 0.03% | 201 |
|
|
2023
Q2 | $268K | Buy |
3,728
+47
| +1% | +$3.38K | 0.03% | 212 |
|
|
2023
Q1 | $270K | Buy |
+3,681
| New | +$270K | 0.03% | 202 |
|
|
2022
Q4 | – | Sell |
-4,312
| Closed | -$232K | – | 252 |
|
|
2022
Q3 | $232K | Buy |
4,312
+691
| +19% | +$37.2K | 0.03% | 228 |
|
|
2022
Q2 | $202K | Sell |
3,621
-475
| -12% | -$26.5K | 0.02% | 250 |
|
|
2022
Q1 | $288K | Sell |
4,096
-134
| -3% | -$9.42K | 0.03% | 239 |
|
|
2021
Q4 | $408K | Buy |
+4,230
| New | +$408K | 0.04% | 206 |
|
|
2021
Q2 | – | Sell |
-2,445
| Closed | -$233K | – | 225 |
|
|
2021
Q1 | $233K | Sell |
2,445
-973
| -28% | -$92.7K | 0.03% | 217 |
|
|
2020
Q4 | $212K | Buy |
+3,418
| New | +$212K | 0.03% | 215 |
|